Randy Fawcett
About Randy Fawcett
Randy Fawcett serves as the Senior Vice President of Finance and Operations at Prothena Corporation plc, where he has worked since 2012. He has extensive experience in finance and operations, having previously held senior roles at Elan, CV Therapeutics, and Gilead Sciences, among others.
Current Role at Prothena Corporation
Randy Fawcett serves as the Senior Vice President of Finance and Operations at Prothena Corporation plc. He has held this position since 2012, contributing to the company's financial strategies and operational efficiency. His responsibilities include managing real estate transactions, overseeing the leasing of over 170,000 square feet of space, and the construction of over 100,000 square feet of office and lab space. Fawcett also plays a crucial role in ensuring financial control and compliance during significant transitions within the organization.
Previous Experience in Finance and Operations
Prior to his current role, Randy Fawcett held various positions in finance and operations across several organizations. He worked at Elan as the Senior Director of Financial Planning & Analysis from 2009 to 2012. He also served as an Associate Director at CV Therapeutics and held a position as Associate Director of Finance at Gilead Sciences. His experience includes managing financial operations and contributing to business development efforts with major pharmaceutical companies.
Educational Background
Randy Fawcett earned his MBA in Finance and Technology Management from the University of California, Davis - Graduate School of Management, where he studied from 2002 to 2004. He also holds a Bachelor of Arts degree in Biology from Princeton University, which he completed from 1991 to 1995. Additionally, he has undergone military education through the U.S. Army Military Education program.
Military Service
Randy Fawcett served in the United States Army Reserve, achieving the rank of Lieutenant Colonel before retiring in 2017. His military service spanned over 22 years, during which he developed leadership and operational skills that have contributed to his professional career in finance and operations.
Key Contributions and Achievements
Throughout his career, Randy Fawcett has played a significant role in supporting equity raises exceeding $600 million since the demerger from Elan. He led the implementation of SAP by Design during the transition from Elan to Prothena, ensuring financial control and compliance. Fawcett also contributed to business development collaborations with Roche and Celgene, which involved significant milestone agreements.